Demographics and baseline characteristics of patients with HT.
| Variables | Patients with HT (n=38) n(%) |
|---|---|
| Demographic variables | |
| Gender | |
| Male | 24 (63.2) |
| Female | 14 (36.8) |
| Nationality | |
| Saudi | 28 (73.7) |
| Non-Saudi | 10 (26.3) |
| Age | |
| Median (IQR) | 66.5 (54.3 -77.5) |
| Stroke severity scores at admission | |
| NIHSS | |
| Median (IQR) | 10.0 (5.0 - 14.2) |
| GCS | |
| Median (IQR) | 14.5 (13.0 - 15.0) |
| Risk factors | |
| HTN | 28 (73.7) |
| DM | 25 (65.8) |
| Hyperlipidemia | 24 (63.2) |
| IHD* | 23 (60.5) |
| Previous stroke | 17 (44.7) |
| A-Fib | 14 (36.8) |
| Smoking | 12 (31.6) |
| CHF† | 5 (13.2) |
| Previous TIA‡ | 3 (7.9) |
| Alcohol use | 1 (2.6) |
| Ischemic etiology | |
| Cardio-embolic | 21 (55.3) |
| Large artery disease | 2 (5.3) |
| Small artery disease lacunar | 1 (2.6) |
| Other | 1 (2.6) |
| Unknown | 13 (34.2) |
| Medications prior to hospitalization | |
| Antiplatelet | 19 (50) |
| Dual Antiplatelet | 18 (47.4) |
| Anticoagulation | 5 (13.2) |
| Lipid-lowering agents | 10 (26.3) |
| Antihypertensive drug | 26 (86.4) |
| Hypoglycemic drug | 16 (42.1) |